Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Star Scientific, Inc. to Contact the Firm NEW YORK, April 19, 2013 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds Star Scientific, Inc. ("Star Scientific" or the "Company") (Nasdaq:STSI) investors of the May 24, 2013 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain executives. A complaint has been filed on behalf of all persons who purchased or otherwise acquired Star Scientific securities between October 31, 2011 and March 18, 2013 (the "Class Period"). The action alleges that the Company mischaracterized the involvement of Johns Hopkins Hospital ("Johns Hopkins") in clinical testing of the Company's nutritional supplement Anatabine. On January 23, 2013, financial news website TheStreet.com published an article refuting claims that Star Scientific was conducting clinical trials with Johns Hopkins. On this news, Star Scientific shares declined $0.31 per share or nearly 12%, to close at $2.44 per share. In January and February 2013, the Company received subpoenas from the US Attorney's office investigating transactions in the Company's securities, including related party transactions, dating back to 2006. On March 18, 2013, the Company disclosed this investigation to investors, announcing that the Company and its directors had received subpoenas from the US Attorney's office. On this news Star Scientific shares declined an additional $0.35 per share, or nearly 18%, to close at $1.63 on March 19, 2013. Request more information now by clicking here:www.faruqilaw.com/STSI. There is no cost or obligation to you. Take Action If you invested in Star Scientific stock or options within the Class Period between October 31, 2011 and March 18, 2013 and would like to discuss your legal rights, visit www.faruqilaw.com/STSI. You can also contact us by calling Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to email@example.com or firstname.lastname@example.org. Faruqi & Faruqi, LLP also encourages anyone with information regarding Star Scientific's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. Attorney Advertising.The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.We welcome the opportunity to discuss your particular case.All communications will be treated in a confidential manner. CONTACT: FARUQI & FARUQI, LLP 369 Lexington Avenue, 10th Floor New York, NY 10017 Attn: Richard Gonnello, Esq. email@example.com Francis McConville, Esq. firstname.lastname@example.org Telephone: (877) 247-4292 or (212) 983-9330
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Star Scientific, Inc. to
Press spacebar to pause and continue. Press esc to stop.